Walter Reinisch

48PUBLICATIONS
115CO-AUTHORS
Disease surveillanceMedical mycologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Forest health and pathologyPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (48)

|Jun 29, 2026
Stoma formation and associated risk factors in patients with Crohn's disease in an Austrian tertiary referral hospital: a retrospective explorative study of long-term follow-up.

|Jun 17, 2026
Histologic and combined histologic-endoscopic outcomes with mirikizumab in Crohn's disease: VIVID-1 trial results.

|May 20, 2026
Time to rethink washout periods in inflammatory bowel disease clinical trials: an international Delphi consensus.

|May 01, 2026
Five-year efficacy and safety of guselkumab for moderately to severely active Crohn's disease: Results from the phase 2 GALAXI 1 trial.

|Apr 24, 2026
Efficacy and safety of ABBV-154 in patients with moderately to severely active Crohn's disease: a phase 2b, randomized, double-blind, placebo-controlled trial.

|Apr 04, 2026
Efficacy and safety of ulcerative colitis therapies do not differ by age: A post hoc analysis of randomized controlled trials.

Emily C L Wong, John K Marshall, Christopher Ma

Pageof 8

Frequent Collaborators

14 joint publications

Neeraj Narula

11 joint publications

Emily C L Wong

10 joint publications

Silvio Danese

4 joint publications

David T Rubin